Yulu Peng, Pei Dong, Hui Han, Fangjian Zhou, Zhiling Zhang. "Cadonilimab combined with lenvatinib for neoadjuvant therapy in early-stage renal cell carcinoma with indications for partial nephrectomy but high surgical risk: A prospective single-arm phase II clinical trial.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.5_suppl.530